Recent reports describe a new class of regulatory elements called super-enhancers [1] [2] [3] . These are defined as enhancer-like elements, bound by master regulators, particularly the Mediator complex, and bearing active chromatin marks such as acetylation of histone H3 at lysine 27 (H3K27ac). Super-enhancers typically comprise a cluster of regulatory elements, spanning up to 12.5 kb, and are frequently flanked by CTCF-binding sites, suggesting that their activity may be constrained by boundary elements 4 . Although originally identified in embryonic stem cells, super-enhancers have been described in many cell types [5] [6] [7] . Together, these studies propose that a relatively small set of super-enhancers act as key switches to determine cell fate. However, it is unclear whether super-enhancers genuinely represent a new paradigm, describing a functional unit that is more than the sum of its parts, or whether they are simply an assembly of conventional enhancers of varying strengths 8 . Therefore, it is important to determine whether there are emergent functional properties uniquely associated with super-enhancers.
Recent reports describe a new class of regulatory elements called super-enhancers [1] [2] [3] . These are defined as enhancer-like elements, bound by master regulators, particularly the Mediator complex, and bearing active chromatin marks such as acetylation of histone H3 at lysine 27 (H3K27ac). Super-enhancers typically comprise a cluster of regulatory elements, spanning up to 12.5 kb, and are frequently flanked by CTCF-binding sites, suggesting that their activity may be constrained by boundary elements 4 . Although originally identified in embryonic stem cells, super-enhancers have been described in many cell types [5] [6] [7] . Together, these studies propose that a relatively small set of super-enhancers act as key switches to determine cell fate. However, it is unclear whether super-enhancers genuinely represent a new paradigm, describing a functional unit that is more than the sum of its parts, or whether they are simply an assembly of conventional enhancers of varying strengths 8 . Therefore, it is important to determine whether there are emergent functional properties uniquely associated with super-enhancers.
Here, using an unbiased approach 1 , we identified all super-enhancers in mouse erythroid cells and found that the two clusters of regulatory elements controlling expression of the α-and β-globin genes are classified as super-enhancers in this cell type. The study of mammalian enhancers is hampered by the observation that these elements are defined by criteria only partially or indirectly related to their role in vivo 9, 10 . We therefore used homologous recombination to generate seven mouse models in which each constituent of the proposed α-globin super-enhancer was deleted, individually and in informative pairs, to dissect its function.
We find that no single element is critical for globin gene expression and, although each element scores as an erythroid enhancer on the basis of conventional chromatin signatures and enhancer assays, only two of the five elements behave as strong enhancers in vivo during embryonic, fetal and adult erythropoiesis. These two strong enhancers fall into a subgroup of individual erythroid enhancers that are bound by the greatest amount of Mediator and the highest numbers of erythroid master regulators. Such regions have been referred to as hotspots 6 . Notably, we find no evidence of emergent functional properties from the extended enhancer cluster; each element seems to contribute to gene expression as an individual enhancer in an additive rather than synergistic manner. Thus, the super-enhancer associated with the globin genes may be more simply described as a group of conventional enhancers including at least one strong enhancer rather than as a new discrete entity with properties greater than the sum of its parts. lysine 4 of histone H3 (<10 reads per million). A substantial proportion of DHSs corresponded to CTCF-binding sites ( Supplementary  Fig. 1a,b) . In the remaining 10,542 DHSs, enhancers were distinguished from promoters by their ratio of H3K4me3 to H3K4me1 signal ( Fig. 1b and Supplementary Fig. 1a) . Finally, this enhancer group was further refined by removing 29 DHSs located within 250 bp of annotated transcription start sites. The resulting set of 1,963 putative enhancers had the chromatin signature previously shown to be enriched at enhancers (Fig. 1a,b) [12] [13] [14] .
To identify erythroid super-enhancers, we used the ROSE algorithm 3 , 'stitching' together individual enhancers within 12.5 kb of each other to define a single entity spanning a contiguous genomic region. The stitched enhancers and the remaining individual enhancers (those without a neighboring enhancer within 12.5 kb) were then ranked by the level of Med1 signal in the extended genomic region. A small number (95) of these enhancer regions (<7%) bound very high levels of Med1. By definition 1, 3 , elements with a Med1 value above a cutoff where the slope of the distribution plot of Med1 ChIP-seq intensity is 1 are designated super-enhancers (Fig. 1c) . The remaining enhancers were considered to be regular enhancers. As in other cell types 1 and by definition, Med1 levels were most informative in distinguishing between super-enhancers and regular enhancers (Supplementary Fig. 1c) .
As in previous studies 1, 15 , super-enhancers often spanned large genomic regions and contained multiple constituent enhancer elements (Fig. 1d) . In erythroid cells, their median size was an order of magnitude greater than that of regular erythroid enhancers (5,650 bp versus 866 bp). As well as the defining enrichment of Med1 (Fig. 1e) , we also found significant enrichment of key erythroid-specific transcription factors (Supplementary Fig. 1d ,e) and their binding motifs (Supplementary Fig. 1f) . The previously reported α-and β-globin gene regulatory regions were the two highest scoring super-enhancers in erythroid cells using Mediator binding as the defining parameter ( Fig. 1c and Supplementary Table 1 ). This was also true using any of the other reported diagnostic parameters (Supplementary Table 1) . Like other super-enhancers 15 , the globin super-enhancer lies close to the cell-type-specific gene it regulates (Fig. 1f) .
The mouse α-globin super-enhancer identified using these methods spans 24 kb and contains five enhancer-like elements, four of which lie in the introns of an adjacent, widely expressed gene (Nprl3) (Fig. 1f) . The entire α-globin cluster is flanked by two pairs of CTCF-binding sites (Fig. 1f) , a common observation for super-enhancers 15 . 
A r t i c l e s
Given that the α-globin super-enhancer typifies this newly proposed class of elements, we used it as a model to examine in detail the structure and function of super-enhancers.
Transcription factor binding varies between super-enhancer components
Each of the constituents of the α-globin super-enhancer is bound by different combinations of erythroid transcription factors and has varying levels of Med1 binding (Fig. 1f) . Analysis of the composition of regular enhancers and super-enhancers showed that, as expected, super-enhancers are enriched for composite enhancers (Fig. 1d) ; the greater the number of constituent elements, the more likely the region will be classified as a super-enhancer (Supplementary Fig. 1g ). An increase in the number of constituent elements correlated with higher levels of Med1 binding (Fig. 2a) . When individual enhancers were ranked for Med1 occupancy without stitching, Med1 binding varied considerably among the five constituent enhancers of the α-globin super-enhancer (Fig. 2b) . Using the same methodology as described above to determine a cutoff, the four evolutionarily conserved α-globin regulatory elements (R1-R4) 16 still fell into the class of highly Med1-bound regions when analyzed as single elements, whereas Rm (a species-specific cis element) fell below the proposed cutoff (Fig. 2b) .
We applied an unbiased clustering approach to further characterize the individual components of all erythroid super-enhancers. A partitioning-around-medoids (PAM) algorithm was used to group similar regulatory elements on the basis of binding levels of the four master erythroid transcription factors Nf-e2, Gata1, Scl and Klf1 and the ubiquitously expressed factor CTCF. In addition to groups of elements that were bound by none (cluster 0) or all (cluster 1) of the transcription factors, we identified 16 further clusters each binding a distinct combination of transcription factors. The PAM clusters were ranked for average Med1 signal per cluster and visualized in a heat map (Fig. 2c) . Motif analysis supported the clustering results, confirming enrichment of binding motifs that Table 2 ). Despite not showing enrichment for transcription factor binding by ChIP-seq, DHSs in cluster 0 (containing approximately 25% of all enhancers) were enriched for binding motifs for Gata1, Gata/Scl and Klf1, indicating that low levels of these erythroid transcription factors may bind to these elements. Interestingly, the ranking of clusters for Med1 binding showed higher levels of Med1 at enhancers containing a larger number of transcription factor binding sites (Fig. 2c,d ). These elements were also more likely to be incorporated in super-enhancers (Fig. 2e) . Although this was the case for elements contained by both regular enhancers and super-enhancers, constituents of the latter had higher levels of Med1 binding than enhancer regions outside super-enhancers.
We investigated whether any of the clusters was over-represented in super-enhancers (Fig. 2d) . Cluster 2, containing enhancers binding all four erythroid transcription factors, was significantly enriched, being present in over 30% of erythroid super-enhancers (1.4 × 10 −12 , χ 2 test). Consistent with the recent identification of transcription factor hotspots as key components of adipogenic super-enhancers 6 , enhancer elements bound by a high number of transcription factors were enriched in erythroid super-enhancers.
We next applied this analysis to the constituent elements of the α-globin super-enhancer (Fig. 2f) . Of the five constituent elements of this super-enhancer, R1 and R2 were both present in cluster 2 and had the highest levels of Med1 binding (Fig. 2c) . The R3 and R4 elements were found in cluster 4, binding lower levels of Med1 and only three of the transcription factors (Gata1, Scl and Klf1). Finally, the mouse-specific regulatory element, Rm, to which only two of the key transcription factors were bound (Nf-e2 and Gata1), was part of PAM cluster 6. Thus, the constituents of the α-globin superenhancer show considerable variation in Med1 and transcription factor binding, raising the possibility that they may vary in their contribution to α-globin gene regulation.
Enhancer assays do not reliably describe super-enhancer elements
Mammalian enhancers are defined as distal genetic elements that positively regulate expression in an orientation-independent manner in heterologous gain-of-function expression experiments. Using a transient in vivo citrine reporter assay in which the reporter construct is not integrated in developing chicken embryos, we tested the enhancer activity of the five elements comprising the α-globin super-enhancer.
Enhancer activity was initially detected in Hamburger-Hamilton (HH) stage 9 chick embryos in the developing blood islands, where it persisted throughout development ( Fig. 3a) , consistent with the expression of globin in these islands. Later during development, enhancer activity was also detected in the circulating blood ( Fig. 3a and Supplementary Video 1) and was most prominent in the heart and head, where the greatest density of red blood cells is found (Fig. 3a, bottom) . Expression was most prominent for the R1 enhancer, whereas the activity of the R2 enhancer was detected more broadly across the head and trunk. R3 and R4 had patterns of expression comparable to that of R2. Rm had the lowest level of late activity in regions other than the blood islands, with only low levels of citrine reporter expression detected in the head. No enhancer activity was observed with the negative control ( Supplementary Fig. 2a ). Consistent with our findings in the PAM analysis, the effects of these non-integrated constructs in transient assays seem to reflect the numbers and types of transcription factor binding sites present in each element. 
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A r t i c l e s
Each element was also tested using the wellestablished mouse transgenic system 17, 18 , where a vector containing a candidate enhancer, a minimal promoter and the lacZ gene is stably integrated into chromatin at random positions in the mouse genome. Examination of whole embryos at embryonic day (E) 12.5 after LacZ staining suggested that only R2 exhibits positive enhancer activity in hematopoietic cells at this time point, with five of seven LacZ-stained embryos exhibiting an expression pattern consistent with erythroid enhancer activity ( Fig. 3b and Supplementary Table 3) . We prepared tissue sections from three LacZ-positive mice for each enhancer construct tested; these sections confirmed strong enhancer activity for R2 and also demonstrated weaker activity for R1, whereas no activity was detected for the remaining three elements (R3, R4 and Rm) (Fig. 3b) . Thus, despite their chromatin signatures, these three elements would not be classified as enhancers by this standard assay; only the two elements with the most extensive transcription factor binding profiles as determined by PAM analysis scored positively in the assay.
No single element is critical for globin gene expression
To determine the contribution of each enhancer to α-globin transcription in the context of the super-enhancer (Fig. 4a) , we generated a knockout mouse model for each constituent element. Knockouts were generated by homologous recombination for all five components of the α-globin super-enhancer (as well as for two informative combinations of knockouts). Two of these deletions (for R2 and R3) have previously been described 19, 14 .
We analyzed the viability of mice homozygous for each individual deletion (Supplementary Table 3) . In all cases, offspring were seen in expected Mendelian ratios, and homozygotes survived to adulthood and bred normally.
To assess whether the loss of individual enhancer elements influenced hematological phenotype, blood counts and smears were examined. No single knockout reduced the hemoglobin concentration in adult mice below the normal range (Fig. 4b) , nor did the individual knockouts result in a significant reduction in either mean red blood cell volume (MCV) or mean red blood cell hemoglobin (MCH) beyond the normal range (Supplementary Fig. 3) , although we noted a non-significant trend toward lower MCV and MCH in the R2 −/− mice (as previously reported 19 ). All hematological data are summarized in Supplementary Table 4 .
We noticed increased variation in staining (polychromasia) in R1 −/− and R2 −/− mice (Fig. 4d) , suggesting that stress erythropoiesis is required to maintain normal hematological parameters in these models. We evaluated this possibility using reticulocyte count and noted significantly increased percentage counts in R1 −/− and R2 −/− mice (Fig. 4c,d) We initially performed quantification of the impact of each enhancer on α-globin transcription using an RNA protection assay and qPCR. These assays showed no consistent evidence of altered α-globin RNA expression in mice homozygous for deletions of individual sites, although we noted a trend toward reduced α-globin RNA levels in R2 −/− mice (as previously described 19 ). However, these techniques evaluate accumulated RNA and, at best, identify fold changes in expression, precluding the identification of fractional changes in RNA levels. We therefore developed a modified method 20 to quantify total and metabolically labeled nascent RNA in populations of synchronously maturing primary erythroid cells from each mouse model. Fetal liver cells were isolated at E12.5 to permit assessment of definitive erythropoiesis in homozygotes of all models, including the embryonically lethal R1 −/− ; R2 −/− model. RNA from equivalent populations of synchronously maturing erythroid cells (Supplementary Fig. 4a ) was quantified using NanoString 21 , enabling simultaneous measurement of expression for all globin genes plus five control genes expressed throughout erythroid maturation. We validated the approach using nascent RNA-seq ( Fig. 5d  and Supplementary Fig. 4b) .
The individual elements of the super-enhancer are not functionally equivalent (Fig. 5a,b) . Deletion of R1 or R2 had a significant and reproducible impact on the synthesis of α-globin RNA. Deletion of R4 had a minor impact. Deletion of R3 or Rm, however, had no discernible effect on α-globin RNA synthesis (Fig. 5b) .
Although the impact of homozygosity for the R1 and R2 deletions on the α-globin:β-globin mRNA ratio was significant, there seemed to be compensation for this imbalance in the peripheral blood. The hemolysis and ineffective erythropoiesis induced by the skewed α-globin:β ratio resulted in increased production of erythroid cells (Fig. 4c,d) ; cells with the greatest imbalance in globin synthesis are likely to be destroyed before leaving the bone marrow, leaving little change in peripheral red blood cells or hematological indices.
Thus, the regulatory effect of the α-globin super-enhancer depends mainly on two elements, R1 and R2; the other three elements seem to contribute very little to the activity of the super-enhancer in vivo. Notably, it can be seen that the super-enhancer does not act as a multicomponent structure; removal of any single element cannot abolish function.
The enhancer elements act in an additive manner
To determine whether the apparently inactive enhancer-like elements have a compensatory role when a major element is removed or if the removal of two elements rather than one might collapse the super-enhancer structure, we generated mice in which both an active (R2) and inactive (we arbitrarily chose R3) enhancer-like element were deleted in cis. We found that homozygotes for this double deletion were born in the normal Mendelian ratios and were viable into adulthood. Adults were indistinguishable from R2 −/− mice both hematologically (Fig. 4b) and transcriptionally (Fig. 5) .
We also generated mice in which both active elements, R1 and R2, were removed in cis. Heterozygotes for the R1/R2 knockout were viable and were able to breed normally. However, cross-breeding of heterozygotes gave reduced litter sizes and no homozygotes for the deletion allele at term. The sacrifice of pregnant females following timed matings showed that R1 −/− ; R2 −/− mice were smaller and paler than wild-type or heterozygote littermates, with nuchal edema (Fig. 5c  and Supplementary Table 4) . These mice died in utero at ~E14.5.
The embryonic lethality of R1 −/− ; R2 −/− mice means that hematological indices could be assessed only in heterozygotes. These mice had reduced MCH and MCV values and increased reticulocyte counts relative to wild-type mice, which are typical of thalassemia (Fig. 4) . Analysis of α-globin:β-globin RNA ratios showed that R1 −/− ; R2 −/− npg A r t i c l e s fetal liver cells produced very little α-globin RNA (Fig. 5) . Further, within the limits of the experimental method, the contributions of R1 and R2 to transcription seemed to be additive rather than clearly synergistic. The remaining normal α-globin RNA in these mice (<10% of the levels in wild-type mice) is likely to be transcribed under the influence of the intact cis elements. Our data suggest that R4 may contribute to this transcription.
The chromatin environment does not depend on the intact super-enhancer
Each cis element in the α-globin regulatory domain is associated with a nuclease-sensitive site, as demonstrated by DNase I sensitivity and ATAC-seq 11 . To determine whether the hypersensitive sites in the α-globin super-enhancer are interdependent, we analyzed the ATAC-seq profile of fetal liver culture erythroid cells from homozygotes for each regulatory element deletion (Fig. 6a) . We show that the presence of no individual hypersensitive site critically depends on that of any other: these sites seem to form independently. Even in the most phenotypically severe R1 −/− ; R2 −/− model, hypersensitive sites still formed at R3, R4 and Rm. In the absence of R1 and R2, the peaks of hypersensitivity at the α-globin promoters were reduced when compared to those for wild-type cells ( Fig. 6a and Supplementary Fig. 5a ). However, in genomewide analysis of R1 −/− ; R2 −/− cells, we found no changes to global hypersensitive site formation beyond those commensurate with between-individual variation (Supplementary Fig. 5b) .
Using next-generation Capture-C 22 , we have previously shown that a region of approximately 70 kb, including the α-globin genes and the super-enhancer, is contained within a tissue-specific 'compartment' in which the individual regulatory elements interact with each other, the promoters of the globin genes and the surrounding chromatin. Assessing these interactions in fetal liver culture erythroid cells from the knockout models demonstrated very little change in the compartment between wild-type cells and those from any single knockout (Fig. 6b) . The intact super-enhancer is therefore not required for the formation or maintenance of the chromatin compartment. 
A r t i c l e s
Although the interactions between the α-globin promoters and the regions around the positions of the R1 and R2 enhancers were markedly reduced in R1 −/− ; R2 −/− cells, they remained above the baseline levels found in embryonic stem cells (Supplementary Fig. 6 ). The interaction between the promoters and the CTCF-binding site located between the deleted enhancers was also reduced, although still present in R1 −/− ; R2 −/− cells, as was the interaction between the promoters and the weaker R4 enhancer. In R2 −/− ; R3 −/− cells, the interactions of the promoters with R1 were diminished, but the interactions with Rm and R4 were virtually unchanged in comparison to those in wild-type cells. These data suggest that the strong distal enhancers R1 and R2 potentiate the interactions between the superenhancer elements (R3, Rm and R4) and the α-globin promoters.
When we extended the assessment of chromosomal conformation across the genome using next-generation Capture-C, the only statistically significant changes seen in even the most phenotypically severe double knockouts were at the α-globin promoters (Supplementary Fig. 7) .
DISCUSSION
On the basis of genome-wide studies pioneered by the Encyclopedia of DNA Elements (ENCODE) Project, a surprisingly large number of regulatory elements have been identified (2.9 million DHSs across various human cell types 23 and ~300,000 cis-regulatory elements in various mouse tissues 24 ). This equates to 15-150 elements for every structural gene. Yet assays of the functional roles of these elements remain suboptimal, typically examining elements outside their natural chromosomal environment, which can give, as we describe, conflicting results.
Further classification of regulatory elements has been driven by the observation that some elements bearing the signatures of enhancers cluster around particular genes in specific tissues. Such clusters of enhancers were first referred to as locus-control regions (LCRs) 25 and then as super-enhancers 1 and stretch enhancers 26 . Clearly, it is important to distinguish between models that propose an emergent property from this grouping (and thus a new type of element, for example, super-enhancers) from a more simple clustering of regular enhancers.
We have systematically addressed this at the mammalian α-globin locus. Here we have shown that the linked α-globin regulatory elements fulfill the criteria for being among the highest ranking superenhancers in erythroid cells. Each component is marked by a DHS, binds key cell-type-specific transcription factors and the Mediator complex, is marked by H3K4me1 and H3K27ac, and produces enhancer RNAs (eRNAs) and long noncoding RNAs (lncRNAs) 14 . Each element scores positively in a transient enhancer assay. Although we have not assessed possible changes in Med1 binding, activating chromatin marks or eRNA production in the context of each enhancer knockout 27 , we have found that each element within the cluster seems to act independently rather than cooperatively. Similarly, removal of two elements does not seem to abrogate the formation of other enhancer elements, showing that the cluster does not act as an interdependent holocomplex. Previous, less extensive studies have also shown that the individual regulatory elements of the β-globin LCR, which we demonstrate here also corresponds to an erythroid super-enhancer, behave in a similar independent and additive manner 28 . Although we cannot extrapolate from these findings to all super-enhancers, previous principles of gene regulation first established for the globin genes have been shown to be generally applicable to other loci.
Notably, we have shown that, although all components of the cluster would be classified as enhancers, they are not functionally equivalent.
Whereas R1 and R2 are strong enhancers in their natural chromosomal environment, R3, Rm and R4 are either very weak enhancers or are not enhancers at all, despite their chromatin marks. Of interest, only R1 and R2 score positively in an enhancer assay in which the sequences are incorporated into chromatin. Further subclassification of all erythroid enhancers shows that R1 and R2 are distinguished by binding the greatest number of cell-type-specific transcription factors and the greatest amount of Mediator, and they are also associated with the most extensively modified chromatin. These sites correspond to elements that others have referred to as hotspots. However, they could more simply be referred to as strong individual enhancers.
From the data presented here and by others 29, 30 , it seems likely that multiple enhancers may provide robustness in gene expression. Removal of either strong enhancer (R1 or R2) at the α-globin locus results in stress erythropoiesis to ensure normal hemoglobin production. Under conditions of environmental or physiological compromise, it is possible that having two strong enhancers rather than one would provide a selective advantage. Such enhancers have previously been referred to as 'shadow enhancers' (ref. 31) .
One puzzle emerging from this study is why enhancer-like elements, which clearly score positively in indirect assays, have no discernible function in their natural chromosomal environment. One possibility is that they do have a weak enhancer function, which is not easily demonstrated by current physiological assays. Alternatively, they may have a more substantial role at different stages of development or may define the polarity of the enhancer; these possibilities have not been tested in this study.
We suggest, however, that these elements reflect evolutionary turnover in cis-acting elements as seen in other studies 32 . It is unlikely that cis-acting elements emerge fully formed during evolution or that they disappear entirely when they lose function; the apparently functionless elements we identify could therefore represent evolving enhancers. Indeed, it has been proposed that transcription factor hotspots, such as R1 and R2, create a permissive chromatin environment for the emergence of new transcription factor binding regions 6 .
Altogether, our data do not support the suggestion that superenhancers have a singular composite function but rather suggest that strong enhancers simply augment the interactions between their chromatin environment and cognate promoters. This generates a compartment of interaction between the chromatin surrounding the enhancer and the promoter, which results in an environment that might favor the evolution of other enhancers.
Our study, together with previous work at the β-globin LCR, does not support further subclassification of enhancers beyond the simple designation of strong to weak elements. These elements may be usefully ranked by the number of lineage-specific transcription factors that they bind, in turn reflected by the degree of binding of Mediator and by the associated activated chromatin modifications. When tested at the α-globin locus, clustering of enhancers in super-enhancers does not appear to lead to any unexplained emergent properties. However, genetic dissection of other super-enhancers in other cell types is warranted to provide a more comprehensive understanding of super-enhancer function.
ONLINE METHODS
Analysis of cis elements. Identification of DHSs, analysis of ATAC accessibility and ChIP-seq to characterize cis-acting elements were performed and data were analyzed as previously described 14, 33 . For ChIP-seq analysis, all data were aligned using Bowtie (version 1.0.0) 34 to the NCBI37/mm9 build of the mouse genome. Alignments were performed with the following parameters: -m 2, -k 1, --best. Enhancers were identified from a peak call of C57BL/6 mouse DNase I-hypersensitive regions.
SeqMonk was used for an independent peak call of two technical replicates of biological duplicate experiments 11 . The ploidy regions, as well as peaks greater or equal in signal to sonication input, were excluded. Each of the files was manually curated to exclude remaining background peaks in MIG 35 . The peak calls were merged to yield a single file with high-confidence DNase I-hypersensitive regions containing 15,849 peaks. To identify putative enhancer elements and to avoid a bias toward a limited set of transcription factors, DNase I-hypersensitive peaks were classified on the basis of the ratio between the coverage of H3K4me1 and H3K4me3 signals within each peak call region. H3K4me1 and H3K4me3 coverage was normalized to a million mapped reads before determining the ratio (using an in-house script, Quantbam.pl). A total of 5,307 peaks were annotated to have low signal for both markers, as both H3K4me1 and H3K4me3 had coverage of <10 reads per million. The rest of the peaks were further divided into putative enhancers and promoters. Regions were annotated as enhancers if the H3K4me3/H3K4me1 ratio was <1. Annotated enhancers that were within 250 bp of refGene annotated transcription start sites were removed from the set.
Super-enhancers were identified using the ROSE tool 1 . Briefly, individual enhancers within 12.5 kb of each other were stitched together to form a single larger enhancer domain. Stitched enhancer domains were then ranked for input-normalized ChIP-seq occupancy of Med1. The x-axis point at which the tangent to a scaled graph with the x and y axes ranging from 0 to 1 that had a slope of 1 was used as a cutoff, above which stitched enhancers were classified as super-enhancers. This same methodology was followed to analyze the erythroid enhancers for occupancy of DNase I, H3K4me1, H3K27ac and a combination of four erythroid transcription factors (Gata1, Scl, Klf1 and Nf-e2). The signal for each of the factors was normalized to a maximum value of 1.0 and visualized after sorting the enhancers by relative signal. To identify individual high-Med1 enhancers, we used the ROSE tool in a similar manner as described above, only specifying a stitching distance (option -s) of 0 and thereby preventing the stitching of individual enhancer elements before downstream analysis.
Factor enrichment analysis. For quantification of ChIP-seq signal, we calculated normalized read density after removal of PCR duplicates. Reads were extended by 200 bp, and we calculated the number of reads per base pair. The calculated read densities were then normalized to the total number of million mapped reads to produce the reads per million mapped per base pair. Finally, ChIP-seq reads per million per base pair values were normalized to input by subtraction. PAM clustering. PAM clustering analysis was performed with the cluster library in R. Before clustering, the coverage for all transcription factors of interest and CTCF (and the sonication input) was determined and downsampled to the Klf1 read counts (the data set with the lowest total number of mapped reads). The sonication input value was subtracted from the coverage values, and 13 reads (the approximate maximum height of Klf1 baseline read depth) were subtracted from all coverage values. All regions that had at least four reads were set to have four reads as the coverage. This essentially led to close to binary clustering, as most regions now had either zero or four reads. After this, the regions were subjected to PAM clustering with 2 to 24 clusters. The clustering results were visually inspected and validated in silhouette plots, and the best clustering (with the fewest outliers and high average silhouette value for all clusters) was seen when our annotated enhancers were divided into 16 clusters. These are clusters 2 to 17, with clusters 0 and 1 being excluded from the clustering (as invariable regions cannot be clustered). Cluster 1 had high signal for all the transcription factors and CTCF, and cluster 0 had no signal for any of the transcription factors or CTCF. To visualize the PAM clusters, they were plotted along the mean Mediator coordinate, so that cluster 2 had the highest mean Mediator signal and cluster 17 had the lowest. In the visualization, all read counts greater than 15 reads in the region are shown as a signal of '15 reads' . All reads were downsampled to the Klf1 signal, the input was subtracted and the Klf1 background of 13 reads was subtracted. The histone marker coverage values were determined by adding ±500 bases of overhang to the peaks before determining the coverage. Sonication input was subtracted using the same ±500 bases of overhang; otherwise, histone coverage was normalized as above. Data were not row normalized but are shown as raw signal.
Motif analysis and heat maps. Transcription factor binding sites in enhancer and promoter elements were identified using HOMER software 36 and were further analyzed by PAM clustering using the cluster library in R.
Motif analysis was performed with the HOMER code annotate Peaks.pl by using (i) peaks with widths as they were given in the peak call file and peaks with (ii) ±400 bases, (iii) ±200 bases and (iv) ±100 bases from the peak center. The results were inspected and used to validate the PAM clustering analysis. To validate the enrichment of erythroid transcription factor motifs in superenhancers, the findMotifs.pl tool from the HOMER suite was used with a peak width of ±200 bp from the center of constituent peaks within super-enhancers. P values correspond to corrected p in the HOMER output. Heat maps were generated using HOMER, version 4.7. The heat maps were visualized in R, using the heatmap.2 library and RcolorBrewer.
Analysis of enhancer elements in transient assays. To clone chick reporter constructs, enhancer regions were amplified from mouse genomic DNA using KAPA HiFi polymerase and the primers described in Supplementary Table 6 . Gel-purified amplicons were cloned using a Golden Gate assembly approach 37 into a new citrine (YFP-variant) reporter vector containing a BsmBI-flanked LacZ expression cassette upstream of the mouse minimal α-globin promoter (HB2) and the citrine fluorescent protein ORF. Negative-control constructs were generated by inserting a short negative-control region instead of an enhancer. The negative-control region was assembled by annealing two oligonucleotides. Endotoxin-free maxi preps were prepared for in vivo electroporation using a Qiagen kit (12362).
Individual reporter constructs together with control construct, ubiquitously expressing histone 2B-tethered RFP, were co-electroporated into the entire epiblast of the early chick gastrula embryos (HH4), as previously described 38 . After electroporation, embryos were allowed to develop to desired stages using ex ovo culture in thin albumin, supplemented with 1% penicillin-streptomycin. Reporter activity was monitored up to 3 d after electroporation using fluorescence microscopy.
Enhancer activity was also assayed using an established mouse transgenic system where a vector containing a candidate enhancer, a minimal promoter and the lacZ gene is stably integrated into the mouse genome via standard pronuclear injection 17, 18 . The coordinates of the enhancer elements assayed in this work are the same as those used for the chick enhancer assays. To visualize LacZ staining on histological sections, embryos were fixed in 4% paraformaldehyde at 4 °C, washed three times in PBS, embedded in OCT compound (Sakura Finetek) and sectioned on a cryostat (Leica) at 10-µm thickness. Specimens were viewed and photographed using a Nikon Eclipse E600 microscope and DXM1200C camera.
Generation of knockout mouse models. All mouse work was performed in accordance with UK Home Office regulations under approved project licenses. Targeting and mouse model generation were performed as previously described 14, 19 . A region of ~1 kb encompassing the conserved sequence for each regulatory element (R1, R2, R3, Rm and R4, as previously described 16 ) was identified for deletion. The region was chosen to include all erythroidspecific transcription factor binding sites, without impinging on other active elements such as CTCF-binding sites. The coding sequence of Nprl3 was preserved. Regions of homology totaling ~7 kb were identified on either side of the planned deletion and were amplified from a mouse 129/Ola-specific α-globin BAC using a high-fidelity Taq polymerase. These regions were cloned into the pGEM-T Easy vector for sequencing before excision with EcoR1, blunting with T4 polymerase and ligation into the unique Srf1 and Bst1107I sites in the pNTFlox targeting vector. In this vector, the homology arms flank a loxP-flanked neomycin resistance gene, whose expression is driven by the PGK promoter. To allow for negative selection, a herpes simplex thymidine kinase
